|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02329 GLORY HEALTH
Nominal 
0.119 -0.010 (-7.752%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -0.992% | -1.541% | 0.355% | 0.132% | 1.089% |
| ROAE (%) | -4.925% | -7.470% | 1.812% | 0.789% | 7.034% |
| Return on Capital Employed (%) | -2.112% | -3.502% | 0.726% | 0.296% | 2.047% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | -2.006% | 2.907% | 12.600% | 16.993% | 26.426% |
| EBITDA Margin (%) | -0.907% | -9.174% | 12.362% | 12.867% | 30.087% |
| Pre-tax Profit Margin (%) | -27.077% | -27.924% | 8.859% | 8.957% | 25.283% |
| Net Profit Margin (%) | -22.502% | -23.377% | 2.307% | 1.712% | 10.623% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.002 X | 0.997 X | 1.186 X | 1.226 X | 1.348 X |
| Quick Ratio (X) | 0.254 X | 0.223 X | 0.303 X | 0.284 X | 0.285 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 75.538% | 74.944% | 74.727% | 77.622% | 77.328% |
| Total Debt / Total Assets (%) | 39.352% | 37.032% | 34.296% | 34.839% | 33.406% |
| Net Debt / Total Assets (%) | 39.219% | 36.805% | 33.543% | 32.492% | 32.752% |
| Total Debt / Shareholders' Funds (%) | 198.549% | 181.121% | 164.842% | 188.279% | 218.798% |
| Long Term Debt / Shareholders' Funds (%) | 94.677% | 77.494% | 104.819% | 123.808% | 154.070% |
| Net Debt / Shareholders' Funds (%) | 197.880% | 180.011% | 161.220% | 175.593% | 214.518% |
| Net Cash / (Debt) ($) | (22.101B) | (21.121B) | (20.486B) | (21.937B) | (26.911B) |
| Net Cash / (Debt) per share ($) | (4.973) | (4.752) | (4.609) | (4.936) | (6.055) |
| Total Debt / Capital Employed (%) | 83.053% | 81.532% | 66.627% | 70.419% | 65.347% |
| Interest Coverage Ratio (X) | N/A | N/A | 2.177 X | 2.060 X | 6.765 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 3312.994 Day | 2425.193 Day | 1229.521 Day | 2851.734 Day | 2557.342 Day |
| Receivables Turnover (Day) | 39.088 Day | 38.001 Day | 20.448 Day | 39.922 Day | 25.231 Day |
| Payables Turnover (Day) | 361.972 Day | 214.118 Day | 93.268 Day | 240.467 Day | 203.901 Day |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -58,659,000 |
| %Change | -78.020% |
| EPS / (LPS) | RMB -0.013 |
| NBV Per Share (¥) | RMB 2.500 |